Therapy Acceleration Program (TAP)
| TAP on a Roll
LLS’s innovative new partnership program, the Therapy Acceleration Program (TAP), continues to grow and help create opportunities for new blood cancer treatments.
Founded in 2007, TAP supports private sector and academic-based projects with the goal of moving more blood cancer therapies into the development pipeline.
The program now has nine partnerships with a range of companies, universities and hospitals. “We’re definitely progressing,” said Louis DeGennaro, Ph.D., LLS’s chief scientific officer. “These partnerships represent the beginning of a fruitful, long-term collaboration with some of the world’s leading innovators.”
TAP partnerships include:
|








